Cargando…
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
Immune-related adverse events (irAEs), caused by anti-PD-1/PD-L1 antibodies, can lead to fulminant and even fatal consequences and thus require early detection and aggressive management. However, a comprehensive approach to identify biomarkers of irAE is lacking. Here, we utilize a strategy that com...
Autores principales: | Jing, Ying, Liu, Jin, Ye, Youqiong, Pan, Lei, Deng, Hui, Wang, Yushu, Yang, Yang, Diao, Lixia, Lin, Steven H., Mills, Gordon B., Zhuang, Guanglei, Xue, Xinying, Han, Leng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532211/ https://www.ncbi.nlm.nih.gov/pubmed/33009409 http://dx.doi.org/10.1038/s41467-020-18742-9 |
Ejemplares similares
-
Sex-associated molecular differences for cancer immunotherapy
por: Ye, Youqiong, et al.
Publicado: (2020) -
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
por: Jing, Ying, et al.
Publicado: (2022) -
Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction
por: Cao, Ting, et al.
Publicado: (2023) -
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019) -
Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors
por: Limeta, Angelo, et al.
Publicado: (2023)